FindTrial
Sign In

the prevalence of APOL1 high risk alleles in dialysis population in the Netherlands

The prevalence of APOL1 high risk alleles in dialysis population in the Netherlands

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
NL-OMON
Registry ID
NL-OMON23827
Enrollment
500
Registered
2019-05-14
Start date
2020-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney disease

Interventions

none

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all adults on dialysis with given informed consent

Exclusion criteria

Exclusion criteria: all patients who dit not give informed consent

Design outcomes

Primary

MeasureTime frame
The primary outcome is the prevalence of two high risks alleles of APOL1 gene in patients on dialysis in Dianet AMC and Utrecht, OLVG Oost and OLVG West.—

Secondary

MeasureTime frame
The secondary outcome is prevalence of the two high risk alleles of APOL1 gene in patients on dialysis from Moroccan descent, from Africa, Suriname and the Netherlands Antilles descent and the prevalence of 1 or none high risk alleles of APOL1 gene.—

Contacts

Public ContactNienke Manson

Amsterdam UMC

n.a.manson@amsterdamumc.nl0031619691543

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)